|
|
|
|
|
|
Sponsors and Collaborators: |
Washington University School of Medicine Genentech |
Information provided by: | Washington University School of Medicine |
ClinicalTrials.gov Identifier: | NCT00500344 |
CNV from AMD is the leading cause of blindness in people over 50 in North America. The hypothesis is to determine if there is an improvement in retinal function determined by ERG following treatment with ranibizumab for AMD
Condition | Intervention | Phase |
Age-Related Macular Degeneration |
Drug: Lucentis (ranibizumab) |
Phase I |
Genetics Home Reference related topics: | X-linked juvenile retinoschisis |
MedlinePlus related topics: | Macular Degeneration |
Drug Information available for: | Ranibizumab |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | CAPTAIN: Choroidal Neovascularization Assessment by Pattern Electroretinography After Ranibizumab in Naive Age-Related Macular Degeneration Patients |
Estimated Enrollment: | 20 |
Study Start Date: | July 2007 |
Estimated Study Completion Date: | December 2008 |
Arms | Assigned Interventions |
1 |
Drug: Lucentis (ranibizumab)
intravitreal injection
|
Show Detailed Description |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Rajendra S Apte, MD, PhD | 314.747.5262 | apte@vision.wustl.edu |
Contact: Pam Light, CCRC | 314.367.1278 ext 2287 | bristudies@barnesretinainstute.com |
United States, Missouri | |||||
Barnes Retina Institute | Recruiting | ||||
St. Louis, Missouri, United States, 63110 | |||||
Contact: Pam Light, CCRC 314-367-1278 ext 2287 bristudies@vision.wustl.edu | |||||
Principal Investigator: Rajendra S. Apte, MD, PhD |
Washington University School of Medicine |
Genentech |
Principal Investigator: | Rajendra S. Apte, MD, PhD | Washington University School of Medicine |
Study ID Numbers: | FVF3799S |
First Received: | July 10, 2007 |
Last Updated: | October 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00500344 |
Health Authority: | United States: Food and Drug Administration |
|
|
|
|